145 related articles for article (PubMed ID: 15640956)
1. Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro.
Bilir A; Guneri AD; Altinoz MA
Neoplasma; 2004; 51(6):460-4. PubMed ID: 15640956
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy studies with gemcitabine.
van Moorsel CJ; Veerman G; Bergman AM; Guechev A; Vermorken JB; Postmus PE; Peters GJ
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-17-S7-23. PubMed ID: 9194475
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine, vinorelbine and cyclooxygenase inhibitors in the treatment of glioblastoma. Ultrastructural analyses in C6 glioma in vitro.
Elmaci İ; Bilir A; Ozpinar A; Altinoz MA
Tissue Cell; 2019 Aug; 59():18-32. PubMed ID: 31383285
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
[TBL] [Abstract][Full Text] [Related]
5. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.
Jung CP; Motwani MV; Schwartz GK
Clin Cancer Res; 2001 Aug; 7(8):2527-36. PubMed ID: 11489836
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer.
Yen Y; Margolin K; Doroshow J; Fishman M; Johnson B; Clairmont C; Sullivan D; Sznol M
Cancer Chemother Pharmacol; 2004 Oct; 54(4):331-42. PubMed ID: 15148626
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.
Liu D; Kojima T; Ouchi M; Kuroda S; Watanabe Y; Hashimoto Y; Onimatsu H; Urata Y; Fujiwara T
Mol Cancer Ther; 2009 Apr; 8(4):980-7. PubMed ID: 19372571
[TBL] [Abstract][Full Text] [Related]
8. Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.
Jørgensen CL; Ejlertsen B; Bjerre KD; Balslev E; Nielsen DL; Nielsen KV
BMC Cancer; 2013 Nov; 13():541. PubMed ID: 24215511
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine in breast cancer: future directions.
Tripathy D
Clin Breast Cancer; 2002 May; 3 Suppl 1():45-8. PubMed ID: 12057046
[TBL] [Abstract][Full Text] [Related]
10. Biological agents and gemcitabine in the treatment of breast cancer.
Morandi P
Ann Oncol; 2006 May; 17 Suppl 5():v177-80. PubMed ID: 16807452
[No Abstract] [Full Text] [Related]
11. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.
Giovannetti E; Mey V; Danesi R; Mosca I; Del Tacca M
Clin Cancer Res; 2004 May; 10(9):2936-43. PubMed ID: 15131028
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.
Ishmael DR; Chen WR; Nordquist JA; Liu H; Nordquist RE
Cancer Invest; 2003 Apr; 21(2):217-26. PubMed ID: 12743987
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model.
Kanzawa F; Saijo N
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-8-S7-16. PubMed ID: 9194474
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and taxanes as a new standard of care in breast cancer.
Yardley DA
Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S107-12. PubMed ID: 14754467
[TBL] [Abstract][Full Text] [Related]
15. Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.
Crane CH; Mason K; Janjan NA; Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S81-4. PubMed ID: 12902862
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.
Hussain A; Mohsin J; Prabhu SA; Begum S; Nusri Qel-A; Harish G; Javed E; Khan MA; Sharma C
Asian Pac J Cancer Prev; 2013; 14(10):5855-60. PubMed ID: 24289589
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of hydroxyurea-resistant leukemic cells to gemcitabine.
Wong SJ; Myette MS; Wereley JP; Chitambar CR
Clin Cancer Res; 1999 Feb; 5(2):439-43. PubMed ID: 10037195
[TBL] [Abstract][Full Text] [Related]
18. Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.
Roman NO; Samulitis BK; Wisner L; Landowski TH; Dorr RT
Cancer Chemother Pharmacol; 2011 Jan; 67(1):183-92. PubMed ID: 20339847
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
Yip-Schneider MT; Sweeney CJ; Jung SH; Crowell PL; Marshall MS
J Pharmacol Exp Ther; 2001 Sep; 298(3):976-85. PubMed ID: 11504793
[TBL] [Abstract][Full Text] [Related]
20. Overview: gemcitabine as single-agent therapy for advanced breast cancer.
Tripathy D
Clin Breast Cancer; 2002 May; 3 Suppl 1():8-11. PubMed ID: 12057038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
